| Document |
Document Title |
|
WO/2024/141543A1 |
The invention concerns a compound of formula (I): the process for the preparation thereof and the use thereof as photoinitiator, preferably as photoinitiator activable under 350-460 nm light irradiation, notably to cure formulations comp...
|
|
WO/2024/140062A1 |
Provided are a thioxanthenium salt photoinitiator, and a preparation method therefor and the use thereof. The thioxanthenium salt photoinitiator has a structure as represented by formula I. The preparation method comprises the following ...
|
|
WO/2024/140063A1 |
Provided in the present application are a thioxanthene sulfonium salt photoinitiator as well as a preparation method therefor and the use thereof. The thioxanthene sulfonium salt photoinitiator has a structure as shown in following formu...
|
|
WO/2024/141537A1 |
The present invention concerns a method of curing a composition comprising a cationically-polymerizable compound and a photoinitiator of formula (I): the method comprising irradiating the composition with at least one light source having...
|
|
WO/2024/144186A1 |
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent diode using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light-emitt...
|
|
WO/2024/142976A1 |
This composition contains a compound represented by formula (1) and a curable compound. In formula (1), PM+ is a cation represented by formula (PM1), and A- is an anion represented by formula (AN1). The present invention pertains to a fi...
|
|
WO/2024/137981A1 |
Provided are compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein Ring A, Ring B, L, RB, Rc, n, and p are as defined herein. Also provided are pharmaceutically acceptable compositions comprising a compound of ...
|
|
WO/2024/130570A1 |
A light emitting diode is provided. The light emitting diode includes a hole injection layer; and at least one of a hole transport layer or an electron barrier layer. The hole injection layer includes a host material doped with a guest m...
|
|
WO/2024/128017A1 |
Provided is a new sulfonium salt that, when being irradiated with light beams having an ultrashort wavelength, quickly degrades and generates an acid. This sulfonium salt is represented by formula (1). In formula (1), R1 represents an ...
|
|
WO/2024/126053A1 |
The present disclosure provides a method of preparing a compound of Formula (V) wherein n of radicals R6' to R9' are -RbOC(O)C(R13) =CH2, and further wherein R13 is H or C1 alkyl, n is an integer of from 1 to 3 and for each of said n rad...
|
|
WO/2024/121129A1 |
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the CIC...
|
|
WO/2024/112123A1 |
The present invention relates to a compound represented by chemical formula 1 described in the present specification, and a pharmaceutical composition for prevention or treatment of cancer, containing same as an active ingredient. It is ...
|
|
WO/2024/088237A1 |
Compounds of a general formula, the use thereof, and an organic electroluminescent device containing same. The compounds have structures represented by formula (1), wherein the dotted line represents ring A being an optional structure; w...
|
|
WO/2024/071980A1 |
The present invention pertains to: a xanthene derivative compound having a high refractive index; and a method for producing same. More specifically, the present invention pertains to: a high refractive index monomer that has a xanthene-...
|
|
WO/2024/048438A1 |
The present invention addresses the problem of providing: a diastereomer preparation method whereby it becomes possible to produce a desired diastereomer from a diastereomer mixture with high efficiency; and a solid-phase photosensitizer...
|
|
WO/2023/230702A1 |
Screening for novel antibacterial compounds in small molecule libraries has a low success rate. Here, we applied a machine learning (ML)-based virtual screening for antibacterial activity and evaluated its predictive power by experimenta...
|
|
WO/2023/223855A1 |
The present invention provides: a compound which is represented by formula (1) (each of the symbols in formula (1) is as defined in the description); an organic electroluminescent element which contains this compound; and an electronic d...
|
|
WO/2023/216432A1 |
The present application relates to a thioxanthone derivative, a method for preparing same, and use thereof. The thioxanthone derivative has a structure represented by formula (1). The thioxanthone derivative provided by the present appli...
|
|
WO/2023/218203A1 |
The present invention relates to compounds that are MALT1 inhibitors. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical c...
|
|
WO/2023/208837A1 |
The present invention relates to oligomeric binaphtyl compounds of the formula (I) that are suitable as monomers for preparing thermoplastic resins, such as polycarbonate resins, which have beneficial optical and mechanical properties an...
|
|
WO/2023/190161A1 |
The present invention provides a polymerization initiator (A) which contains a dialkyl peroxide (a-1) that has a thioxanthone skeleton represented by general formula (1) and a hydroperoxide (a-2) that has a thioxanthone skeleton represen...
|
|
WO/2023/151662A1 |
Provided are an androgen receptor activity regulator and the use thereof. The androgen receptor activity regulator has a structure as represented by formula 1-I or formula 2-I, wherein R1-R7, X, ring A, ring B, ring C, n, m, p, Z1 and Z2...
|
|
WO/2023/153169A1 |
The present disclosure provides an organic compound represented by general formula (1). (In general formula (1), R1 to R20 are each independently selected from the group consisting of a hydrogen atom, a deuterium atom, a halogen atom, an...
|
|
WO/2023/151394A1 |
The present invention relates to the technical field of organic electroluminescent materials, and in particular, to a fluorene derivative and a use thereof. The structural formula of the fluorene derivative is shown in formula (I). The f...
|
|
WO/2023/126223A1 |
The present invention relates to novel photoinitiators having hydroxyl groups and/or (meth)acrylate groups. The invention also relates to compositions comprising these photoinitiators as well as their use for photopolymerizing ethylenica...
|
|
WO/2023/023594A9 |
2‑diarylmethyl‑4‑aminotetrahydropyran derivatives are disclosed. The compounds include the following genus: or a pharmaceutically acceptable salt thereof. The compounds activate cellular PP2A, suppress oncogenic kinase signaling an...
|
|
WO/2023/078824A1 |
The present invention relates to compounds of the spiro-(indane- fluorene) type of formula (I), in particular those bearing a primary amino group and the corresponding diarylamino compounds. The invention further relates to methods for p...
|
|
WO/2023/051657A1 |
Provided are a compound as represented by formula I, and a racemate, an enantiomer, a diastereomer and a pharmaceutically acceptable salt thereof, and the use thereof in the prevention or treatment of related diseases caused by coronavir...
|
|
WO/2023/026884A1 |
To provide a curable composition that generates little outgas from an obtained cured product. The curable composition includes a radical polymerization initiator represented by formula 1 and a radical polymerizable compound. In formula 1...
|
|
WO/2023/011416A1 |
The present invention provides a compound targeting HDAC and NAD synthesis and a pharmaceutically acceptable salt, hydrate, deuterated substance, isomer, or prodrug of the compound, and preparation and application thereof. Specifically, ...
|
|
WO/2023/277605A1 |
The present invention provides a novel compound for a capping layer and an organic light-emitting device containing same.
|
|
WO/2023/277593A1 |
The present invention provides a novel compound for a capping layer, and an organic light-emitting device comprising same.
|
|
WO/2022/235264A1 |
Applicants have developed novel methods and compositions for controlling, treating, preventing, or ameliorating arthropod infection and identifying kinin receptor agonists and antagonists. Novel compositions include one or more active ag...
|
|
WO/2022/191312A1 |
[Abstract] [Problem] To provide a method for producing a dealkoxyphenylation product with high yield from a substrate, e.g., a sugar, which is bonded to an alkoxyphenyl group through an oxygen atom. [Solution] A substrate that is bonded ...
|
|
WO/2022/184292A1 |
The present invention relates to novel Norrish Type II photoinitiators which may be liquid or easily solubilized at room temperature. The invention also relates to compositions comprising these photoinitiators as well as their use for ph...
|
|
WO/2022/174525A1 |
The present invention relates to the fields of medicinal chemistry and pharmacotherapeutics, and in particular to a compound, a preparation method therefor and a use thereof, relating to the technical field of pharmacy. Provided are a co...
|
|
WO/2022/172685A1 |
Provided are a method for forming a resist pattern having excellent performance including sensitivity during a light exposure process, LWR performance and CDU performance even when a next-generation light exposure technology is applied t...
|
|
WO/2022/162471A1 |
Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.
|
|
WO/2022/157274A1 |
The invention relates to a polymerizable photoinitiator, to a process for preparing a polymerizable photoinitiator, to a polymerizable composition comprising a polymerizable photoinitiator and an ethylenically unsaturated compound. The i...
|
|
WO/2022/105845A1 |
A glucoside derivative, and a preparation method therefor and an application thereof. Specifically, provided is a glucoside derivative, which is a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof. The ...
|
|
WO/2022/091691A1 |
A compound having at least one group represented by general formula (11) and including only one benz[de]anthracene derivative skeleton represented by general formula (1000) in the molecule. Ar1 is a substituted or unsubstituted aryl grou...
|
|
WO/2022/071116A1 |
A purpose of the present invention is to provide a thioxanthone compound having excellent reactivity to long-wavelength light. The present invention relates to a photopolymerization initiator comprising the thioxanthone compound, a curab...
|
|
WO/2022/060020A1 |
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light-...
|
|
WO/2022/054554A1 |
Provided is a highly active actinic-ray-sensitive acid generator which, upon irradiation with actinic rays, comes to have cationic-polymerization performance or crosslinking reaction performance and which enables curable compositions con...
|
|
WO/2022/053845A1 |
With the present invention, a compound [OH-TX-S-]2, gold nanoparticles (AuNps) coated with a coating layer containing same, AuNPs synthesized with a PdI of 0.45±0.01 and a core diameter of 30±1 nm, and the versions thereof coated with ...
|
|
WO/2022/025117A1 |
The present invention provides the compound represented in general formula (A1) [Ar1 is a C6-14 aryl group or a C5-14 nitrogen-containing heteroaryl group, substituted with at least two electron-attracting groups; R1 is a C1-30 alkyl gro...
|
|
WO/2022/022372A1 |
Disclosed in the present invention are a thiobenzopyran compound as shown in formula I and an application of a pharmaceutically acceptable salt of the thiobenzopyran compound in preparation of a drug for treating rheumatoid arthritis, wh...
|
|
WO/2022/018968A1 |
The present invention provides a useful photoacid generator which is contained in a photocurable composition, a chemically amplified positive photoresist composition and a chemically amplified negative photoresist composition, and which ...
|
|
WO/2021/249566A1 |
Provided are a benzo six-membered ring derivative for treating liver fibrosis and use thereof. Specifically, provided are a compound as shown in formula (I), a pharmaceutical composition containing the compound of formula (I), and use of...
|
|
WO/2021/246363A1 |
A purpose of the present invention is to provide a sealing agent for liquid crystal display elements, which has excellent curability at light shielded parts and which is capable of preventing gelling and thickening when dissolving a phot...
|
